help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jobe, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jobe, A. H.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1529-1530, (2002)
© 2002 American Thoracic Society


Editorial

An Unknown

Lung Growth and Development after Very Preterm Birth

Alan H. Jobe

Division of Pulmonary Biology Cincinnati Children's Hospital Cincinnati, Ohio

The airways are well formed by 20 weeks gestation in the human. The distal lung parenchyma transitions from the canalicular to the saccular stage of lung development at about the time of earliest extrauterine viability at 23 to 24 weeks gestation. Alveoli begin to appear after 32 weeks gestation, and perhaps 30% of the adult number of alveoli have formed by term (1). Lung development after preterm birth must proceed in the extrauterine environment while providing gas exchange. There are a number of reports demonstrating that preterm birth per se results in alterations in lung function that are most apparent in the early years of life and subsequently become less evident as children age. Most of the reports have focused on airway function and responses to bronchodilators. Recently, however, AJRCCM published a report from Hjalmarson and Sandberg (2) comparing lung function of "normal" preterm infants measured at term with term infants. The preterms, born at a mean gestational age of 29.5 weeks, had dysfunction of terminal respiratory units and higher elastic recoil. The results are consistent with altered alveolarization after preterm birth. Because airway development precedes development of the alveoli and the pulmonary microvasculature, disturbances of the parenchymal development might be anticipated to be more severe than airway abnormalities after very preterm birth.

There are limitations to the currently available information that confound our understanding of the degree, characteristics, and implications of preterm birth and any subsequent lung injury on lifelong lung function. A major concern is that more immature infants are surviving and are at risk of lung injury and subsequent abnormal lung development. In this issue of AJRCCM (1539–1543), Hofhuis and coworkers (3) report that ventilated infants with a mean birth weight of about 850 g and who were oxygen dependent at 36 weeks gestation had abnormal FEF rates at 6 and 12 months corrected postnatal age. That these infants with a history of bronchopulmonary dysplasia had quite abnormal airway function is not new. The surprising and new result is that the FEFs deteriorated between 6 and 12 months of age. Moreover, the infants ventilated with high frequency oscillation did not have the decreased FEFs noted for conventionally ventilated infants at 12 months of age. These results are provocative and cause concern because the expectation is for airway disease to abate with growth as the airways enlarge.

This first description of an increase in functional airway disease over the first year of life may represent the additive adverse effects of very preterm birth plus bronchopulmonary dysplasia at a time when the infants are growing very rapidly. They may be functionally growing out of their airways. The findings may result in part from how the patients were managed in the newborn period. The ventilation strategies were not described in any detail, and most of the infants were exposed to high dose, long-duration dexamethasone treatments. Glucocorticoids are known to delay alveolar septation in the developing lung (4).

The result that infants ventilated by high-frequency oscillation had abnormal but not deteriorating FEFs is quite speculative, I believe. The infants were not randomized for style of ventilation and were selected for the follow-up measurements of lung function based only on the presence of bronchopulmonary dysplasia. Any benefits of high-frequency oscillation over conventional ventilation are controversial and far from definitive, as again illustrated by two recently published large multicenter trials, one showing modest benefit and the other showing no benefit of high-frequency ventilation (5, 6). The bronchopulmonary dysplasia that occurs in very preterm infants is an evolving disease (7). Severe airway injury and parenchymal fibrosis is less common than was described for larger preterm infants before the era of increased survival of very preterm infants. This increased survival, but with a high incidence of bronchopulmonary dysplasia, is associated with the use of antenatal steroids, postnatal surfactant, and more careful attention to minimizing lung injury with mechanical ventilators (8, 9). High-frequency oscillation could result in less lung injury if the conventional ventilation provided inadequate positive end-expiratory pressure to maintain the functional residual capacity and to maintain the airways open during expiration. Muscedere and coworkers (10) clearly demonstrated that airway injury can be minimized by adequate positive end-expiratory pressure in an experimental model of surfactant deficiency. Differences in outcomes between conventional ventilators and oscillators may relate more to the way they are used than to the intrinsic characteristics of the devices.

This interesting report of decreased FEFs with age in very preterm infants may represent the tip of a very large iceberg, which is abnormal lung parenchymal development. Very small infants who have died of bronchopulmonary dysplasia have strikingly simplified lungs with increased alveolar sizes, decreased alveolar numbers, and a dysplastic pulmonary vasculature. These abnormalities persist for months in preterm baboons exposed to excessive oxygen and mechanical ventilation (11). Jacob and coworkers (12) reported in AJRCCM in 1998 that infants with birth weights of about 1 kg had decreased exercise capacity at 10 years of age. The 10-year-olds with a history of bronchopulmonary dysplasia used 93% of their ventilatory reserve during exercise relative to 59% for a term comparison group also tested at 10 years of age. Mitchell and Teague (13) also reported in AJRCCM in 1998 that somewhat larger infants with a history of bronchopulmonary dysplasia (1.4 kg average birth weight) had decreased carbon monoxide transfer during rest and exercise and decreased oxygen saturations during exercise relative to term controls when tested at 7 years of age. These abnormalities probably reflect significant and persistent disruptions of development of the gas exchange surface. We desperately need morphologic information about the lung parenchyma and airways of survivors of prematurity and bronchopulmonary dysplasia to be able to better interpret physiologic tests of lung function. Tissue could be collected from children who have survived prematurity and bronchopulmonary dysplasia and who occasionally die from nonpulmonary causes. The long-term prognosis for lung function with aging remains an unknown.

REFERENCES

  1. Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA, editors. Structural aspects of prenatal and postnatal development and growth of the lung. New York: Marcel Dekker, Inc.; 1997. p. 1–35.
  2. Hjalmarson O, Sandberg K. Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 2002;165:83–87.[Abstract/Free Full Text]
  3. Hofhuis W, Huysman MWA, van der Wiel EC, Holland WPJ, Hop WCJ, Brinkhorst G, de Jongste JC, Merkus PJFM. Worsening of V'maxFRC in infants with chronic lung disease in the first year of life: a more favorable outcome after high-frequency oscillation ventilation. Am J Respir Crit Care Med 2002;166:1539–1543.[Abstract/Free Full Text]
  4. Massaro DJ, Massaro GD. The regulation of the formation of pulmonary alveoli. In: Bland RD, Coalson JJ, editors. The regulation of the formation of pulmonary alveoli. New York: Marcel Dekker, Inc.; 2000. p. 479–492.
  5. Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, Calvert SA. High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 2002;347:633–642.[Abstract/Free Full Text]
  6. Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 2002;347:643–652.[Abstract/Free Full Text]
  7. Jobe A, Bancalari E. NICHD/NHLBI/ORD workshop summary—bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–1729.[Free Full Text]
  8. Hussain NA, Siddiqui NH, Stocker JR. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710–717.[CrossRef][Medline]
  9. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Bland RD, Coalson JJ, editors. Pathology of chronic lung disease of early infancy. New York: Marcel Dekker, Inc.; 2000. p. 85–124.
  10. Muscedere JG, Mullen JBM, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994;149:1327–1334.[Abstract]
  11. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995;152:640–646.[Abstract]
  12. Jacob SV, Lands LC, Coates AL, Davis GM, MacNeish CF, Hornby L, Riley SP, Outerbridge EW. Exercise ability in survivors of severe bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997;155: 1925–1929.[Abstract]
  13. Mitchell SH, Teague WG. Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1998;157:1406–1412.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
NEJMHome page
E. Cutz, D. Chiasson, V. Kiren, E. Barbi, A. Ventura, M. Filippone, and E. Baraldi
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
N. Engl. J. Med., February 14, 2008; 358(7): 743 - 743.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Friedrich, P. M. C. Pitrez, R. T. Stein, M. Goldani, R. Tepper, and M. H. Jones
Growth Rate of Lung Function in Healthy Preterm Infants
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1269 - 1273.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. Baraldi and M. Filippone
Chronic Lung Disease after Premature Birth
N. Engl. J. Med., November 8, 2007; 357(19): 1946 - 1955.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Henschen, J. Stocks, I. Brookes, and U. Frey
New aspects of airway mechanics in pre-term infants
Eur. Respir. J., May 1, 2006; 27(5): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. Hofhuis, J. C. de Jongste, P. J. F. M. Merkus, C. W. Bollen, C. S. P. M. Uiterwaal, and A. J. van Vught
High-Frequency Ventilation in Premature Neonates
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 466 - 467.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. R. Thomas, G. F. Rafferty, E. S. Limb, J. L. Peacock, S. A. Calvert, N. Marlow, A. D. Milner, and A. Greenough
Pulmonary Function at Follow-up of Very Preterm Infants from the United Kingdom Oscillation Study
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 868 - 872.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Gappa, J. Stocks, P. Merkus, and A. H. Jobe
Lung Growth and Development after Preterm Birth: Further Evidence
Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 399 - 400.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 333 - 344.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jobe, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jobe, A. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society